pre-ipo
Stage
1
Investors
About
4D Molecular Therapeutics discovers and develops novel adeno-associated virus (AAV) vectors for gene therapy products targeting monogenic disorders.
Explore 4D Molecular Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.